197 related articles for article (PubMed ID: 27760227)
1. Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer.
Hrebien S; O'Leary B; Beaney M; Schiavon G; Fribbens C; Bhambra A; Johnson R; Garcia-Murillas I; Turner N
PLoS One; 2016; 11(10):e0165023. PubMed ID: 27760227
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA.
Toro PV; Erlanger B; Beaver JA; Cochran RL; VanDenBerg DA; Yakim E; Cravero K; Chu D; Zabransky DJ; Wong HY; Croessmann S; Parsons H; Hurley PJ; Lauring J; Park BH
Clin Biochem; 2015 Oct; 48(15):993-8. PubMed ID: 26234639
[TBL] [Abstract][Full Text] [Related]
3. Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging.
García-Saenz JA; Ayllón P; Laig M; Acosta-Eyzaguirre D; García-Esquinas M; Montes M; Sanz J; Barquín M; Moreno F; Garcia-Barberan V; Díaz-Rubio E; Caldes T; Romero A
BMC Cancer; 2017 Mar; 17(1):210. PubMed ID: 28330468
[TBL] [Abstract][Full Text] [Related]
4. Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis.
O'Leary B; Hrebien S; Beaney M; Fribbens C; Garcia-Murillas I; Jiang J; Li Y; Huang Bartlett C; André F; Loibl S; Loi S; Cristofanilli M; Turner NC
Clin Chem; 2019 Nov; 65(11):1405-1413. PubMed ID: 31551314
[TBL] [Abstract][Full Text] [Related]
5. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients.
Oshiro C; Kagara N; Naoi Y; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2015 Apr; 150(2):299-307. PubMed ID: 25736040
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.
Parpart-Li S; Bartlett B; Popoli M; Adleff V; Tucker L; Steinberg R; Georgiadis A; Phallen J; Brahmer J; Azad N; Browner I; Laheru D; Velculescu VE; Sausen M; Diaz LA
Clin Cancer Res; 2017 May; 23(10):2471-2477. PubMed ID: 27827317
[No Abstract] [Full Text] [Related]
8. Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.
Liang DH; Ensor JE; Liu ZB; Patel A; Patel TA; Chang JC; Rodriguez AA
Breast Cancer Res Treat; 2016 Jan; 155(1):139-49. PubMed ID: 26667234
[TBL] [Abstract][Full Text] [Related]
9. Direct circulating tumor DNA detection from unpurified plasma using a digital PCR platform.
Sefrioui D; Beaussire L; Perdrix A; Clatot F; Michel P; Frebourg T; Di Fiore F; Sarafan-Vasseur N
Clin Biochem; 2017 Nov; 50(16-17):963-966. PubMed ID: 28645720
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of circulating tumor DNA stability In K
Kang Q; Henry NL; Paoletti C; Jiang H; Vats P; Chinnaiyan AM; Hayes DF; Merajver SD; Rae JM; Tewari M
Clin Biochem; 2016 Dec; 49(18):1354-1360. PubMed ID: 27129799
[TBL] [Abstract][Full Text] [Related]
11. Use of cell free DNA in breast oncology.
Canzoniero JV; Park BH
Biochim Biophys Acta; 2016 Apr; 1865(2):266-74. PubMed ID: 27012505
[TBL] [Abstract][Full Text] [Related]
12. Development of multiplex digital PCR assays for the detection of PIK3CA mutations in the plasma of metastatic breast cancer patients.
Corné J; Le Du F; Quillien V; Godey F; Robert L; Bourien H; Brunot A; Crouzet L; Perrin C; Lefeuvre-Plesse C; Diéras V; De la Motte Rouge T
Sci Rep; 2021 Aug; 11(1):17316. PubMed ID: 34453076
[TBL] [Abstract][Full Text] [Related]
13. Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer.
Kodahl AR; Ehmsen S; Pallisgaard N; Jylling AMB; Jensen JD; Laenkholm AV; Knoop AS; Ditzel HJ
Mol Oncol; 2018 Jun; 12(6):925-935. PubMed ID: 29689598
[TBL] [Abstract][Full Text] [Related]
14. Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
Sato KA; Hachiya T; Iwaya T; Kume K; Matsuo T; Kawasaki K; Abiko Y; Akasaka R; Matsumoto T; Otsuka K; Nishizuka SS
PLoS One; 2016; 11(1):e0146275. PubMed ID: 26727500
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.
Madic J; Kiialainen A; Bidard FC; Birzele F; Ramey G; Leroy Q; Rio Frio T; Vaucher I; Raynal V; Bernard V; Lermine A; Clausen I; Giroud N; Schmucki R; Milder M; Horn C; Spleiss O; Lantz O; Stern MH; Pierga JY; Weisser M; Lebofsky R
Int J Cancer; 2015 May; 136(9):2158-65. PubMed ID: 25307450
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis.
Parisi C; Mastoraki S; Markou A; Strati A; Chimonidou M; Georgoulias V; Lianidou ES
Clin Chim Acta; 2016 Oct; 461():156-64. PubMed ID: 27510924
[TBL] [Abstract][Full Text] [Related]
17. The In Vitro Stability of Circulating Tumour DNA.
Henao Diaz E; Yachnin J; Grönberg H; Lindberg J
PLoS One; 2016; 11(12):e0168153. PubMed ID: 27959945
[TBL] [Abstract][Full Text] [Related]
18. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
Thierry AR
Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
[TBL] [Abstract][Full Text] [Related]
19. Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients.
de Bruin EC; Whiteley JL; Corcoran C; Kirk PM; Fox JC; Armisen J; Lindemann JPO; Schiavon G; Ambrose HJ; Kohlmann A
PLoS One; 2017; 12(5):e0175779. PubMed ID: 28472036
[TBL] [Abstract][Full Text] [Related]
20. Circulating Plasma Tumor DNA.
Parsons HA; Beaver JA; Park BH
Adv Exp Med Biol; 2016; 882():259-76. PubMed ID: 26987539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
